Search - tctmd.com

Displaying 141 - 160 of 440

Sort: Relevancy | Date

Presentation TCT 2014

The Sirolimus-Eluting Stent-Balloon: Update of the Abluminus ABL-1 Study

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Sameer I. Dani

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, John A. Ormiston

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Shigeru Saito

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Pedro A. Lemos

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Ricardo A. Costa

September 15, 2014

Presentation TCT 2014

TCT 367: Two-Year Sequential OCT Follow-up Findings and 3-Year Clinical Outcomes of the New Dual Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting COMBO Stent: The EGO-COMBO Study

Presenter: David P. Faxon, Stephen Wai Luen Lee, MD

September 15, 2014

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Industry News

STENTYS Reaches 10,000 Self-Apposing Stent Implantations

September 03, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Daily News

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

L.A. McKeown

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

L.A. McKeown

September 02, 2014

Advertisement

The Sirolimus-Eluting Stent-Balloon: Update of the Abluminus ABL-1 Study

Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

TCT 367: Two-Year Sequential OCT Follow-up Findings and 3-Year Clinical Outcomes of the New Dual Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting COMBO Stent: The EGO-COMBO Study

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

Keynote Address Focuses on Newer DES, Problematic Subgroups

COMBO Stent Achieves Neointimal Regression at 24 Months

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

STENTYS Reaches 10,000 Self-Apposing Stent Implantations

PROTECT: ZES Sustain Lead Over SES at 5 Years

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content